Biopharmaceutics is a pivotal field within the Food and Drug Administration's (FDA) purview, where the intersection of biology and pharmaceuticals takes center stage. This discipline focuses on the study of how drugs are absorbed, distributed, metabolized, and excreted by the body, with a keen eye on the biological factors influencing drug performance.
The FDA plays a crucial role in evaluating the safety and efficacy of biopharmaceuticals, ensuring that these innovative drugs meet rigorous standards before reaching the market. This involves a comprehensive assessment of the biological and chemical properties of these compounds, understanding their behavior in the human body, and predicting their therapeutic impact.
The dynamic landscape of biopharmaceutics aligns with the FDA's commitment to advancing public health by fostering the development of cutting-edge therapies. By staying at the forefront of scientific advancements, the FDA continues to navigate the evolving terrain of biopharmaceutics, contributing to the approval of novel, life-changing treatments that meet the highest standards of quality and effectiveness.
Submit your abstract Today
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India